Singapore markets closed

Nektar Therapeutics (NKTR)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
1.2400-0.0800 (-6.06%)
At close: 04:00PM EDT
1.2300 -0.01 (-0.81%)
After hours: 07:57PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts3344
Avg. Estimate-0.19-0.19-0.88-0.71
Low estimate-0.22-0.22-1.21-1
High estimate-0.17-0.15-0.65-0.31
Year ago EPS-0.73-0.27-1.45-0.88
Revenue estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts3344
Avg. Estimate15.34M15.34M67.51M62.27M
Low estimate5.4M5.4M22.2M22.9M
High estimate20.62M20.62M85.33M81.92M
Year ago salesN/A20.5M90.12M67.51M
Sales growth (year/est)N/A-25.20%-25.10%-7.80%
Earnings history30/03/202329/06/202329/09/202330/12/2023
Est. EPS-0.25-0.28-0.2-0.21
Actual EPS-0.73-0.27-0.24-0.22
Difference-0.480.01-0.04-0.01
Surprise %-192.00%3.60%-20.00%-4.80%
EPS trendCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Current estimate-0.19-0.19-0.88-0.71
7 days ago-0.19-0.19-0.88-0.71
30 days ago-0.19-0.19-0.88-0.71
60 days ago-0.16-0.15-0.76-0.54
90 days ago-0.15-0.14-0.69-0.53
EPS revisionsCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesNKTRIndustrySector(s)S&P 500
Current qtr.74.00%N/AN/AN/A
Next qtr.29.60%N/AN/AN/A
Current year39.30%N/AN/AN/A
Next year19.30%N/AN/AN/A
Next 5 years (per annum)-7.30%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A